查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1715414

免疫血液学市场按产品类型、应用和最终用户划分－2025-2030 年全球预测

Immunohematology Market by Product Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计免疫血液学市场在 2024 年的价值将达到 22.2 亿美元，在 2025 年增长至 24 亿美元，到 2030 年将达到 35.9 亿美元，复合年增长率为 8.27%。

主要市场统计数据
基准年2024年 22.2亿美元
预计2025年 24亿美元
预测年份 2030 35.9亿美元
复合年增长率（%） 8.27%

随着技术进步和实践发展共同重新定义诊断和患者照护，免疫血液学领域正处于一个令人兴奋的十字路口。血液相容性测试、抗体检测和先进系统整合领域的最新技术进步正在将传统的实验室工作流程转变为更简化、准确和自动化的流程。本介绍性概述深入探讨了提高免疫血液学服务的分析准确性和业务效率的进展，为本文奠定了基础。近年来，新技术彻底改变了常规协议，推动了从手动程序到更先进的自动化系统的模式转移。此外，对更快、更准确的测试结果的需求正在加速对新试剂、系统和诊断平台的投资。随着研究人员和决策者寻求利用这些尖端能力，这种转变反映了医疗保健领域的更广泛趋势，其中资料主导的洞察力和创新解决方案正在成为改善患者治疗结果的重要组成部分。

随着对精准诊断和技术无缝整合的日益重视，这种动态格局使免疫血液学成为创新的沃土。该报告深入说明了推动市场发展的因素、满足特定产品和用户需求的細項分析以及影响市场动态的区域差异。这项全面的分析旨在为行业相关人员提供他们所需的洞察力，以驾驭和利用当前趋势，确保他们的实验室服务不仅满足当前需求，而且还为未来做好准备。

重新定义免疫血液学诊断的变革性转变

免疫血液学的发展以变革性的变化为标誌，重新定义了整个诊断领域。近年来，自动化和数位化整合取代了传统的检测方法，为提高准确性、效率和吞吐量铺平了道路。实验室采用最先进的分析设备和系统，不仅加快了测试过程，而且还确保了整个诊断过程的品质始终如一。这种转变是由不断提高业务绩效的动力和对支援更快临床决策的整合式资料管理系统日益增长的需求所推动的。

全自动系统的进步显着提高了抗体检测的敏感度和特异性，从而降低了人为错误的风险并提高了整体诊断信心。相关人员也看到对半自动化平台的需求激增，这些平台可以灵活处理复杂的诊断场景并在自动化和手动监督之间取得平衡。对全面诊断覆盖的需求，以及业界对资源最佳利用的关注，正在推动对技术创新和研究型倡议的强劲投资。因此，这种转变不仅重新定义了目前的临床实践，而且为免疫血液学检测的可靠性和效率设定了新的基准。

深入了解免疫血液学检查的关键领域

对市场的详细研究揭示了复杂的细分动态，为免疫血液学提供了关键见解。分析主要分为三个维度。首先，从产品类型来看，市场是依照分析设备和系统等仪器与试剂、套件等结合来分析的。透过评估分析仪器和系统子区隔可以获得更深入的理解。此子区隔进一步分为提供高吞吐量的全自动平台和允许手动控制的半自动化选项。这种细緻的分类可以对各种实验室环境中的技术层级和产品采用率进行详细评估。

其次，基于应用的细分突显了免疫血液学系统在几个关键测试领域的多样化效用。该框架包括抗体筛检、输血安全通讯协定、准确的疾病诊断、妊娠监测等，每个方面都在推动市场成长方面发挥着至关重要的作用。横断面分析提供了对每个应用如何促进整体市场需求的洞察，并强调了当前诊断解决方案所解决的独特挑战。

此外，市场根据最终用户进行细分，以满足血库、诊断实验室、医院和研究机构等不同机构的不同需求。这种分类有助于理解采购模式、预算分配和特定服务要求的差异。透过交叉分析产品类型、应用和最终用户的细微差别，細項分析不仅可以揭示当前的市场状况，还可以帮助确定未来创新和扩张的机会。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 血液疾病和自体免疫疾病的盛行率不断上升，推动了对详细检测的需求。
      • 加强公众意识和教育宣传活动，促进安全捐血和血液检测实践
      • 扩大政府投资和公共卫生倡议，提高血液安全标准
    • 限制因素
      • 先进诊断设备及耗材试剂高成本
    • 机会
      • 扩大分子诊断和基因分型工具在输血医学中的应用，以支持免疫血液学环境中的个人化治疗计划
      • 免疫血液学诊断的技术进步和自动化程度的提高正在提高检测的准确性和操作效率。
    • 任务
      • 复杂的监管要求和漫长的核准时间阻碍了产品的快速推出
  • 市场区隔分析
    • 产品类型：大型血库和临床实验室越来越多地采用分析仪和系统
    • 应用：增加免疫血液学在怀孕期间筛检母体抗体的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 免疫血液学市场（依产品类型）

  • 分析仪器和系统
    • 全自动
    • 半自动
  • 试剂和套件

第七章免疫血液学市场：依应用

  • 抗体筛检
  • 输血
  • 疾病诊断
  • 怀孕

第 8 章 免疫血液学市场（依最终使用者）

  • 血库
  • 诊断实验室
  • 医院
  • 研究组织

9.美洲免疫血液学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

10. 亚太免疫血液学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 11 章欧洲、中东和非洲免疫血液学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • AliveDx Suisse SA
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomed Global
  • Cardinal Health, Inc.
  • CSL Limited
  • DIAGAST
  • F. Hoffmann-La Roche Ltd.
  • Grifols, SA
  • Immucor, Inc.
  • Merck KGaA
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC.
Product Code: MRR-43127F7279CA

The Immunohematology Market was valued at USD 2.22 billion in 2024 and is projected to grow to USD 2.40 billion in 2025, with a CAGR of 8.27%, reaching USD 3.59 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.22 billion
Estimated Year [2025] USD 2.40 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 8.27%

The field of immunohematology stands at an exciting juncture as technological advancements and evolving practices converge to redefine diagnostics and patient care. In the realm of blood compatibility testing, antibody detection, and advanced system integrations, recent innovations have transformed traditional laboratory workflows into more streamlined, accurate, and automated processes. This introductory overview sets the stage by delving into how advancements have bolstered the analytical accuracy and operational efficiency of immunohematology services. Over the past few years, emerging technologies have led to a comprehensive re-assessment of routine protocols, driving a paradigm shift from manual testing techniques to more sophisticated automated systems. Further, the demand for both faster turnarounds and precision in test results has accelerated investment in novel reagents, systems, and diagnostic platforms. As researchers and decision-makers look to harness these cutting-edge capabilities, the transformation reflects broader trends within healthcare, where data-driven insights and innovative solutions are becoming essential ingredients for improved patient outcomes.

This dynamic landscape, punctuated by an increasing emphasis on precision diagnostics and seamless integration of technology, makes immunohematology a fertile ground for innovation. The ensuing discussion is intricately designed to provide a detailed exploration of the drivers behind market evolution, segmented analysis that addresses product and user-specific needs, and the regional disparities that shape market dynamics. This comprehensive analysis aims to equip industry stakeholders with the insights necessary to navigate and leverage current trends, ensuring that laboratory services not only meet current demands but also remain future-ready.

Transformative Shifts Redefining Immunohematology Diagnostics

The evolution of immunohematology is marked by transformative shifts that have redefined the entire diagnostic landscape. In recent years, automation and digital integration have supplanted conventional testing methodologies, paving the way for enhanced accuracy, efficiency, and throughput. Laboratories are adopting cutting-edge analyzers and systems which not only accelerate the testing process but also ensure consistent quality across diagnostic procedures. This shift is driven by the relentless pursuit of improved operational performance and the increasing need for integrated data management systems that support rapid clinical decision-making.

Advancements in fully-automated systems have introduced significant improvements in the sensitivity and specificity of antibody detection, thereby reducing the risk of human error and enhancing overall diagnostic confidence. Stakeholders have also witnessed a surge in the demand for semi-automated platforms, which strike a balance between automation and manual oversight, offering flexibility in handling complex diagnostic scenarios. The industry's focus on optimal resource utilization, alongside the need for comprehensive diagnostic coverage, has stimulated robust investment across both technological innovations and research-oriented initiatives. Consequently, these transformative changes are not only redefining current practices but are also setting new benchmarks for reliability and efficiency in immunohematology testing.

Key Segmentation Insights in Immunohematology

A closer examination of the market reveals intricate segmentation dynamics that provide critical insights into the immunohematology landscape. The analysis is subdivided primarily along three dimensions. First, in terms of product type, the market is analyzed through the lens of devices such as analyzers and systems paired with reagents and kits. An in-depth understanding is offered by evaluating the sub-segment of analyzers and systems, which is further segmented into fully-automated platforms that offer high throughput and semi-automated options that allow for controlled human input. This nuanced categorization enables a detailed appraisal of the technological hierarchy and product adoption rates across various laboratory settings.

Next, the segmentation based on application underscores the diversified utility of immunohematology systems across several critical testing domains. The framework encompasses antibody screening, blood transfusion safety protocols, precise disease diagnosis, and monitoring pregnancy, each playing a vital role in driving market growth. The cross-sectional analysis provides insights into how each application contributes to overall market demand and highlights the unique challenges addressed by current diagnostic solutions.

Furthermore, the market is segmented by end-users, capturing the differential needs across institutions such as blood banks, diagnostic laboratories, hospitals, and research institutes. This categorization is instrumental in understanding the variances in procurement patterns, budget allocations, and service-specific requirements. By interlacing the nuances of product type, application, and end-user, the segmentation analysis not only illuminates the market's current state but also helps pinpoint future opportunities for innovation and expansion.

Based on Product Type, market is studied across Analyzers & Systems and Reagents & Kits. The Analyzers & Systems is further studied across Fully-Automated and Semi-Automated.

Based on Application, market is studied across Antibody Screening, Blood Transfusion, Disease Diagnosis, and Pregnancy.

Based on End-User, market is studied across Blood Banks, Diagnostic Laboratories, Hospitals, and Research Institutes.

Global Regional Perspectives in Immunohematology

Regional perspectives offer a multi-faceted view of the global immunohematology market, highlighting both mature and emerging sectors. In the Americas, a strong emphasis on advanced healthcare technologies and significant investment in research and development has positioned the region as one of the prominent hubs for implementing sophisticated diagnostic solutions. Conversely, the Europe, Middle East & Africa cluster demonstrates a diverse range of practices where traditional methodologies are being rapidly supplemented by modern technological interventions, ensuring a delicate balance between legacy systems and innovative instruments. In the Asia-Pacific region, rapid urbanization combined with increasing investments in healthcare infrastructure is fostering an environment ripe for adoption of next-generation diagnostic platforms. This regional analysis showcases the interplay between economic growth, healthcare policies, and technological advancements in shaping the landscape of immunohematology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights into Leading Industry Players Driving Innovation

A review of key market players offers additional layers of insight into competitive strategies and technological trends that dominate the immunohematology sector. Industry leaders such as Abbott Laboratories and AliveDx Suisse SA continue to push the envelope in diagnostic innovation, setting benchmark standards for product efficacy and reliability. Organizations like Beckman Coulter, Inc. and Becton Dickinson and Company have shown consistent commitment to integrating automation into clinical practices. Other notable contributors including Bio-Rad Laboratories, Inc. and Biomed Global, as well as Cardinal Health, Inc. and CSL Limited, have successfully combined rigorous research with product development to address gaps in the market.

The influence extends further through companies like DIAGAST and F. Hoffmann-La Roche Ltd., whose research-driven initiatives catalyze new product lines. Grifols, S.A. and Immucor, Inc. are recognized for their role in enhancing operational efficiencies in blood banks and diagnostic labs. Industry giants such as Merck KGaA and QuidelOrtho Corporation provide robust solutions that span a variety of diagnostic applications, while Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., and VWR International, LLC lead the pack with their expansive portfolios that continually raise the bar in terms of clinical precision and patient outcomes. The cumulative efforts of these market players underscore a competitive yet collaborative drive towards innovation in immunohematology.

The report delves into recent significant developments in the Immunohematology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AliveDx Suisse SA, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomed Global, Cardinal Health, Inc., CSL Limited, DIAGAST, F. Hoffmann-La Roche Ltd., Grifols, S.A., Immucor, Inc., Merck KGaA, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., and VWR International, LLC.. Actionable Recommendations to Strengthen Market Leadership

For industry leaders navigating this complex and rapidly evolving landscape, strategic initiatives are imperative to maintain a competitive edge. Key recommendations include investing in integrated diagnostic platforms that combine automation with cutting-edge research to enhance test accuracy and operational efficiency. Leaders should consider forging strategic alliances with technology providers to develop robust systems that respond to the growing demand for both fully-automated and semi-automated solutions, ensuring a scalable approach to laboratory modernization.

Moreover, diversification in product portfolios coupled with an emphasis on customized solutions tailored to the unique needs of different testing applications-ranging from antibody screening to disease diagnosis-will prove to be a crucial differentiator. Embracing data analytics to forecast market trends, optimizing supply chain operations, and maintaining agility in response to regulatory changes also remain top priorities. By aligning operational strategies with evolving market dynamics, decision-makers can not only cement their leadership position in the immunohematology space but also drive sustainable growth and innovation.

Synthesis and Forward-Looking Perspectives

In conclusion, the immunohematology landscape is witnessing an unprecedented convergence of innovation, operational refinement, and evolving consumer expectations. The insights shared through the segmentation, regional analysis, and competitive landscape underscore the transformative potential of technological advancements and strategic investment. As laboratories and healthcare institutions increasingly embrace modern diagnostic tools, the necessity for integrated, efficient, and precise systems becomes more critical than ever. Industry stakeholders must leverage these insights to navigate challenges, capitalize on emerging trends, and drive operational excellence across all facets of immunohematology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of hematological disorders and autoimmune diseases driving demand for precise testing
      • 5.1.1.2. Rising public awareness and education campaigns promoting safe blood donation and screening practices
      • 5.1.1.3. Growing government investments and public health initiatives aimed at enhancing blood safety standards
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced diagnostic equipment and consumable reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of molecular diagnostics and genotyping tools in transfusion medicine to support personalized treatment plans in immunohematology settings
      • 5.1.3.2. Technological advancements in immunohematology diagnostics coupled with automation improvements are enhancing test accuracy and operational efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory requirements and prolonged approval timelines that hinder swift product introductions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising adoption of analyzers & systems for high-volume blood banks and clinical laboratories
    • 5.2.2. Application: Growing application of immunohematology in pregnancy to screen for maternal antibodies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunohematology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Analyzers & Systems
    • 6.2.1. Fully-Automated
    • 6.2.2. Semi-Automated
  • 6.3. Reagents & Kits

7. Immunohematology Market, by Application

  • 7.1. Introduction
  • 7.2. Antibody Screening
  • 7.3. Blood Transfusion
  • 7.4. Disease Diagnosis
  • 7.5. Pregnancy

8. Immunohematology Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals
  • 8.5. Research Institutes

9. Americas Immunohematology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunohematology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunohematology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zoetis launches a cartridge-based AI hematology analyzer designed to revolutionize immunohematology diagnostics
    • 12.3.2. Massive Bio's launch of the Synergy-AI platform at ASCO 2024 transforms clinical trial matching
    • 12.3.3. Sysmex and CellaVision extend their strategic alliance until 2038 to integrate next-generation cell morphology analyzers
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AliveDx Suisse SA
  • 3. Beckman Coulter, Inc.
  • 4. Becton Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Biomed Global
  • 7. Cardinal Health, Inc.
  • 8. CSL Limited
  • 9. DIAGAST
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Grifols, S.A.
  • 12. Immucor, Inc.
  • 13. Merck KGaA
  • 14. QuidelOrtho Corporation
  • 15. Siemens Healthineers AG
  • 16. Sysmex Corporation
  • 17. Thermo Fisher Scientific, Inc.
  • 18. VWR International, LLC.

LIST OF FIGURES

  • FIGURE 1. IMMUNOHEMATOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. IMMUNOHEMATOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. IMMUNOHEMATOLOGY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOHEMATOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY FULLY-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 192. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024